| Related Articles |
Drug repositioning an alternative for the treatment of coronavirus COVID-19.
Int J Antimicrob Agents. 2020 Apr 09;:105969
Authors: Serafin MB, Bottega A, Foletto VS, da Rosa TF, Hörner A, Hörner R
Abstract
Given the extreme importance of the current pandemic caused by COVID-19, and due to the fact that scientists agree that there is no identified pharmacological treatment where possible therapeutic alternatives are raised through drug repositioning. We present a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-Cov, with potential use in the treatment of COVID-19 disease.
PMID: 32278811 [PubMed - as supplied by publisher]